NFKB1 and diffuse large B-cell lymphoma: Although a deletion mutation in TNFAIP3 has been reported in 1 of 8 EBV+ DLBCL samples tested [16], other mutations associated with NF-κB activation have yet to be identified in EBV+ DLBCL.